These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1926249)

  • 21. [Livedo reticularis, cerebrovascular disorders and mitral disease: a new cause of Sneddon's syndrome?].
    Vaillant L; Larmande P; Arbeille B; Desveaux B; Gruel Y; Lorette G
    Ann Dermatol Venereol; 1990; 117(12):925-30. PubMed ID: 2082786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Sneddon syndrome: diagnostic value of antiphospholipid antibodies].
    Martínez Hernández PL; López Guzmán A; Espinosa Arranz E; Monereo Alonso A; Arnalich Fernández F
    Rev Clin Esp; 1991 Oct; 189(6):272-4. PubMed ID: 1763211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sneddon's syndrome associated with anticardiolipin antibody: a case report.
    Mutluer N; Yiğit A; Aydin N
    Acta Neurol Belg; 1992; 92(4):234-8. PubMed ID: 1441902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracerebral hemorrhage associated with Sneddon's syndrome: is ischemia-related angiogenesis the cause? Case report and review of the literature.
    Aquino Gondim Fde A; Leacock RO; Subrammanian TA; Cruz-Flores S
    Neuroradiology; 2003 Jun; 45(6):368-72. PubMed ID: 12750866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sneddon's syndrome and the primary antiphospholipid syndrome].
    Kalashnikova LA; Nasonov EL; Stoianovich LZ; Kovalev VIu; Kosheleva NM; Reshetniak TM
    Ter Arkh; 1993; 65(3):64-70. PubMed ID: 8059389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Sneddon's syndrome: its clinical characteristics and etiopathogenic factors].
    Sempere AP; Martínez B; Bermejo F; Tahoces ML; Cabello A
    Rev Clin Esp; 1992 Jun; 191(1):3-7. PubMed ID: 1631358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sneddon's syndrome: diagnosis by skin biopsy and MRI in 17 patients.
    Stockhammer G; Felber SR; Zelger B; Sepp N; Birbamer GG; Fritsch PO; Aichner FT
    Stroke; 1993 May; 24(5):685-90. PubMed ID: 8488523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sneddon's syndrome: clinical course and outcome.
    Weissenborn K; Lubach D; Schwabe C; Becker H
    J Neurol; 1989 Jan; 236(1):34-7. PubMed ID: 2487780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebral microembolism in patients with Sneddon's syndrome.
    Sitzer M; Söhngen D; Siebler M; Specker C; Rademacher J; Janda I; Aulich A; Steinmetz H
    Arch Neurol; 1995 Mar; 52(3):271-5. PubMed ID: 7872880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Sneddon's syndrome and antiphospholipid antibodies].
    Pérez Sempere A; Martínez Menéndez B; Bermejo F
    Neurologia; 1992 Nov; 7(9):280-1. PubMed ID: 1445719
    [No Abstract]   [Full Text] [Related]  

  • 31. Protein Z deficiency in antiphospholipid-negative Sneddon's syndrome.
    Ayoub N; Esposito G; Barete S; Soria C; Piette JC; Francès C
    Stroke; 2004 Jun; 35(6):1329-32. PubMed ID: 15105516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Spontaneous abortions in Sneddon's syndrome].
    Dikova Ch; Kolarov G; Baleva M; Nikolov K
    Akush Ginekol (Sofiia); 2000; 39(2):24-5. PubMed ID: 10948615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiphospholipid antibodies and Sneddon's syndrome.
    Vargas JA; Yebra M; Pascual ML; Manzano L; Duŕantez A
    Am J Med; 1989 Nov; 87(5):597. PubMed ID: 2816979
    [No Abstract]   [Full Text] [Related]  

  • 34. [Sneddon's syndrome and systemic lupus erythematosus with cerebrovascular disturbances and widespread livedo].
    Kalashnikova LA; Dobrynina LA; Reshetniak TM; Aleksandrova EA; Lozhnikova SM; Gulevskaia TS; Nasonov EL
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(7):21-5. PubMed ID: 16117142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of anti-endothelial cell antibodies in patients with Sneddon's syndrome.
    Francès C; Le Tonquèze M; Salohzin KV; Kalashnikova LA; Piette JC; Godeau P; Nasonov EL; Youinou P
    J Am Acad Dermatol; 1995 Jul; 33(1):64-8. PubMed ID: 7601948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sneddon's syndrome and phospholipid antibodies.
    Mesa HA; Lang B; Schumacher M; Vaith P; Peter HH
    Clin Rheumatol; 1993 Jun; 12(2):253-6. PubMed ID: 8358989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Familial inflammatory Sneddon's syndrome-case report and review of the literature.
    Szmyrka-Kaczmarek M; Daikeler T; Benz D; Koetter I
    Clin Rheumatol; 2005 Feb; 24(1):79-82. PubMed ID: 15340865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiphospholipid antibodies in systemic lupus erythematosus and Sneddon's syndrome.
    Söhngen D; Wehmeier A; Specker C; Schneider W
    Semin Thromb Hemost; 1994; 20(1):55-63. PubMed ID: 8059234
    [No Abstract]   [Full Text] [Related]  

  • 39. [Neurological appearances of primary antiphospholipid syndrome].
    Kalashnikova LA; Dobrynina LA; Aleksandrova EN; Novikov AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; (Suppl 13):19-24. PubMed ID: 15986822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Disorders of the cerebral circulation and other neurological manifestations of the antiphospholipid syndrome].
    Kalashnikova LA
    Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(10):65-73. PubMed ID: 9424353
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.